111 related articles for article (PubMed ID: 4056874)
1. Reduced systemic drug exposure by combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage.
Oldfield EH; Dedrick RL; Yeager RL; Clark WC; DeVroom HL; Chatterji DC; Doppman JL
J Neurosurg; 1985 Nov; 63(5):726-32. PubMed ID: 4056874
[TBL] [Abstract][Full Text] [Related]
2. Arterial drug infusion with extracorporeal removal. II. Internal carotid carmustine in the rhesus monkey.
Oldfield EH; Dedrick RL; Chatterji DC; Yeager RL; Girton ME; Kornblith PL; Doppman JL
Cancer Treat Rep; 1985 Mar; 69(3):293-303. PubMed ID: 2983894
[TBL] [Abstract][Full Text] [Related]
3. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL
Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
Shapiro WR; Green SB; Burger PC; Selker RG; VanGilder JC; Robertson JT; Mealey J; Ransohff J; Mahaley MS
J Neurosurg; 1992 May; 76(5):772-81. PubMed ID: 1564540
[TBL] [Abstract][Full Text] [Related]
5. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
[TBL] [Abstract][Full Text] [Related]
7. Ischemic optic neuropathy secondary to intracarotid infusion of BCNU.
Pickrell L; Purvin V
J Clin Neuroophthalmol; 1987 Jun; 7(2):87-92. PubMed ID: 2956289
[TBL] [Abstract][Full Text] [Related]
8. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
Kapp J; Vance R; Parker JL; Smith RR
Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey.
Levin VA; Kabra PM; Freeman-Dove MA
J Neurosurg; 1978 Apr; 48(4):587-93. PubMed ID: 416182
[TBL] [Abstract][Full Text] [Related]
10. Aspiration of blood from the jugular vein during intracarotid drug infusion in monkeys. Implications for extracorporeal drug removal.
Clark WC; Daniels CE; Dedrick RL; Girton ME; Doppman JL; Oldfield EH
J Neurosurg; 1985 Apr; 62(4):576-9. PubMed ID: 3973728
[TBL] [Abstract][Full Text] [Related]
11. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view.
Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R
Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050
[TBL] [Abstract][Full Text] [Related]
12. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
Hochberg FH; Pruitt AA; Beck DO; DeBrun G; Davis K
J Neurosurg; 1985 Dec; 63(6):876-80. PubMed ID: 2997415
[TBL] [Abstract][Full Text] [Related]
13. Orbital angiographic changes after intracarotid BCNU chemotherapy.
Gebarski SS; Greenberg HS; Gabrielsen TO; Vine AK
AJNR Am J Neuroradiol; 1984; 5(1):55-8. PubMed ID: 6421125
[TBL] [Abstract][Full Text] [Related]
14. Solvent systems for intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) infusion.
Ross RL; Kapp JP; Hochberg F; Krull IS; Ding XD; Selavka C
Neurosurgery; 1983 May; 12(5):512-4. PubMed ID: 6866232
[TBL] [Abstract][Full Text] [Related]
15. [Internal carotid arterial BCNU perfusion in the treatment of cerebral glioma].
Wu ZL
Zhonghua Wai Ke Za Zhi; 1989 Jul; 27(7):421-3, 446. PubMed ID: 2598744
[TBL] [Abstract][Full Text] [Related]
16. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
Kapp JP; Vance RB
J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
[TBL] [Abstract][Full Text] [Related]
17. Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors.
Bremer AM; Kleriga E; Nguyen TQ; Balsys R; Northup HM; Gonzalez N; Duarte P; Miller RI
J Neurooncol; 1984; 2(2):129-32. PubMed ID: 6481425
[TBL] [Abstract][Full Text] [Related]
18. Effect of difluoromethylornithine on the antiglioma therapeutic efficacy of intra-arterial BCNU.
Cohen AR; Pietronigro DD; Cravioto H; Flamm ES
J Neurosurg; 1986 Nov; 65(5):671-8. PubMed ID: 3095505
[TBL] [Abstract][Full Text] [Related]
19. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
Bobo H; Kapp JP; Vance R
J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma: catheter techniques for isolated chemotherapy perfusion.
Doppman JL; Dedrick RL; Shook DR; Lutz RJ; Goldstein SR; Blacklock JB; Boretos JW; Paul RH; Austin HA; Bowman RL
Radiology; 1986 May; 159(2):477-83. PubMed ID: 3961181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
